617 filings
Page 4 of 31
8-K
n5t4tt1 kqetd98yj
9 Nov 20
Other Events
5:25pm
424B5
pylfe8o c8ji3l
9 Nov 20
Prospectus supplement for primary offering
5:13pm
8-K
xnf9lvsh670tz
4 Nov 20
TG Therapeutics Highlights Data Selected for Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting
8:50pm
8-K
3bn95aw9dgmt83gry xc
10 Aug 20
TG Therapeutics Provides Business Update and Reports Second Quarter 2020 Financial Results
7:30am
8-K
eyqx7t
24 Jun 20
Departure of Directors or Certain Officers
5:00pm
PX14A6G
tbtskor pc1zt
29 May 20
Letter to shareholders
11:16am
8-K
n7xdx jze
18 May 20
Entry into a Material Definitive Agreement
5:00pm
424B5
lqqkupq5pc
18 May 20
Prospectus supplement for primary offering
4:02pm
424B5
qw6qx
14 May 20
Prospectus supplement for primary offering
5:18pm
8-K
jvvbppknvsrw ds
11 May 20
TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
5:16pm
8-K
p259j9 mr5f5iffo
5 May 20
Other Events
7:30am
8-K
u9fweshml226
30 Apr 20
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
7:31am
DEFA14A
h2f02
29 Apr 20
Additional proxy soliciting materials
4:32pm
424B5
8rqhidv nov779i
20 Mar 20
Prospectus supplement for primary offering
4:54pm
8-K
ajo17 v2ct
20 Mar 20
Other Events
4:39pm
8-K
2duova
3 Mar 20
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2019 Financial Results
7:22am